Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORIGIN: Lenalidomide vs Chlorambucil in Elderly CLL
NCT00910910Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Oct 2009
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 27
01
Overview
A Phase 3 trial of lenalidomide in chronic lymphocytic leukemia (CLL), sponsored by Celgene Corporation. Started Oct 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00910910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910910.